Body weight change associated kidney outcomes of sodium-glucose cotransporter new users.

Takahiro JimbaHidehiro KanekoTatsuhiko AzegamiYuta SuzukiAkira OkadaToshiyuki KoKatsuhito FujiuNorifumi TakedaHiroyuki MoritaKaori HayashiAkira NishiyamaKoichi NodeHideo YasunagaNorihiko TakedaMasaomi NangakuIssei Komuro

Published in: Diabetes, obesity & metabolism (2024)

Our analysis of a nationwide epidemiological cohort revealed that kidney outcomes following the initiation of SGLT2 inhibitors would be more favourable, with greater body weight loss observed after the initiation of SGLT2 inhibitors.

Keyphrases

body weight
weight loss
bariatric surgery
roux en y gastric bypass
cross sectional
gastric bypass
metabolic syndrome
weight gain